Skip to main content
TipRanks
Go Ultimate75% OFF

Kyverna Therapeutics, Inc. (KYTX) Cash flow

1,056 Followers

Kyverna Therapeutics, Inc. Cash Flow

KYTX's free cash flow for Q3 2026 was $-35.54M. For the 2026 fiscal year, KYTX's free cash flow was decreased by $-174.00K and operating cash flow was $-35.37M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -153.71M$ -114.25M$ -52.41M$ -36.11M$ -22.16M
$ 40.02M$ -160.90M$ -8.79M$ -14.10M$ -1.29M
$ 141.17M$ 337.11M$ 58.12M$ 11.88M$ 72.52M
$ 124.64M$ 97.17M$ 35.21M$ 38.29M$ 76.62M
$ -153.72M$ -116.45M$ -53.03M$ -36.88M$ -23.44M

Currency in USD

Kyverna Therapeutics, Inc. Cash Flow

-200M-100M0100M200M300M400M20212022202320242025OperatingInvestingFinancing